Management

Print
Homepage  >  MEDTOX Info  >  Investors  >  Management

Richard J. Braun, MBA, JD
Chairman/President/CEO

Richard J. Braun, MBA, JD, was named Chairman of the Board of Directors and President on October 26, 2000. Mr. Braun was named a director and elected as Chief Executive Officer in July 1996. From 1994 until joining the Company, Mr. Braun acted as a private investor and provided management consulting services to the health care and technology industries. From 1992 until 1994, he served as Chief Operating Officer and as a director of EBP, Inc., a NYSE company engaged in managed care. From 1989 through 1991, Mr. Braun served as Executive Vice President, Chief Operating Officer and as a director of Reich and Tang L.P., a NYSE investment advisory and broker dealer firm.

B. Mitchell Owens, MBA
Vice President and COO - Diagnostics Division

Mitchell Owens, MBA, was named Vice President and Chief Operating Officer of MEDTOX Diagnostics, Inc. on July 17, 2000. Mr. Owens has over 22 years of experience in the diagnostics industry. He joined the Company in 1988 and has served in various positions including Director of Operations and General Manager. Prior to joining the Company, Mr. Owens was employed by GTE Technical Products Division and Kayser-Roth Corporation in related operations management positions.

Susan E. Puskas, MT (ASCP) SC
Vice President, Quality Assurance, Regulatory Affairs, and COO - Clinical Laboratory Operations

Susan E. Puskas was named COO, Clinical Laboratory Operations on June 15, 2010, in addition to her position as Vice President, Quality Assurance and Regulatory Affairs which she has held since May 23, 2002. Ms. Puskas is a board certified Medical Technologist and Specialist in Clinical Chemistry through the American Society of Clinical Pathologists. Ms. Puskas has been with MEDTOX since 1991. With over 25 years of clinical laboratory experience (greater than 20 years as a manager/supervisor), she oversees the quality systems and regulatory affairs of the company as well as the clinical laboratory operations.

James A. Schoonover, MBA
Vice President and CMO - Sales & Marketing

James A. Schoonover, MBA, was named Vice President of Sales and Marketing and Chief Marketing Officer on July 17, 2000. Mr. Schoonover joined the Company in August 1997 and has more than 25 years of experience in sales, public relations and sales management for a variety of service companies. Prior to joining MEDTOX Scientific, Inc., Mr. Schoonover was a Division Vice President for the medical services subsidiary of Olsten Corporation.

Kevin J. Wiersma
Vice President, Chief Administrative Officer, and CFO of MEDTOX Scientific, Inc., and COO - Forensic Laboratory Operations

Kevin J. Wiersma was named Chief Administrative Officer on June 15, 2010.  He was named Chief Financial Officer on May 22, 2002 and Chief Operating Officer on July 17, 2000. He was named Vice President on July 20, 1998. Mr. Wiersma joined MEDTOX Laboratories in 1992 and continued with the company following its acquisition by MEDTOX Scientific, Inc. Mr. Wiersma has served in various positions relating to finance and operations management within the Company.

NEWS & INSIGHTS

View UPS Shipping Detail

Revisions to HHS and DOT workplace drug testing programs.     Starting October 1, 2010, the required use of the new DOT chain-of-custody form will go into effect.  The new forms cannot be used before 10/1/2010.  MEDTOX will begin taking orders for the new forms on 9/13/2010.  Please ensure you have a sufficient supply of the current DOT forms for all DOT collections until the 10/1/2010 transition date.   DOT Details

Workplace Drug Testing Updates

© 2008 MEDTOX Scientific, Inc. All rights reserved.